BCLI - Brainstorm falls as FDA posts briefing docs on ALS therapy
2023-09-25 08:45:00 ET
More on BrainStorm
- Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics
- Historical earnings data for BrainStorm Cell Therapeutics
- Financial information for BrainStorm Cell Therapeutics
- Brainstorm Cell Therapeutics: I Anticipate A Positive AdCom But There Are Major Risks
- BrainStorm announces data from its Phase 3 trial of NurOwn
For further details see:
Brainstorm falls as FDA posts briefing docs on ALS therapy